In Brief: Everest Medical
This article was originally published in The Gray Sheet
Everest Medical: Receives notice from the U.S. Patent Office of the issuance of a patent for the firm's BiCOAG forceps. The patent design "embodies a bipolar grasping dissecting forceps with independent movable jaws with rotation," Everest states. Use of the product "minimizes the need for multiple instrument changes," representing potential cost savings, the firm says; Everest commenced shipments of the product in late 1994...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.